Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13683591 | 0.80 | L3MBTL1 (0.37) | MEN1MAPTKMT2ALMNAGAA | |
| SCHEMBL14610263 | 0.57 | MAPT (0.50) | MEN1MAPTKMT2ALMNAGAA | |
| SCHEMBL13683597 | 0.56 | MEN1 (0.30) | MEN1MAPTKMT2ALMNAGAA | |
| SCHEMBL13683641 | 0.54 | RECQL (0.55) | L3MBTL1 | |
| SCHEMBL10013323 | 0.54 | — | — | |
| SCHEMBL14016516 | 0.53 | — | — | |
| SCHEMBL14016145 | 0.53 | — | — | |
| SCHEMBL14267879 | 0.52 | MAPT (0.35) | MEN1MAPTKMT2ALMNAGAA | |
| SCHEMBL13270867 | 0.52 | CTSD (0.30) | LMNA | |
| SCHEMBL13974402 | 0.50 | RECQL (0.33) | L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1619040-B1 | Thermal transfer recording material and thermal transfer recording method | DAINIPPON PRINTING CO LTD (JP) | 2008-11-19 | — | — | EP | disclosed |